Christopher Austin - Future of Health Summit 2018

Christopher Austin

Director, National Center for Advancing Translational Sciences, National Institutes of Health

Since 2012, Christopher Austin has served as director of the National Center for Advancing Translational Sciences at the National Institutes of Health. Prior to this role, he was NCATS’ scientific director, focusing on translating basic science discoveries into new treatments and technologies to improve the efficiency of therapeutic/diagnostic development. He founded several initiatives, including the NIH Chemical Genomics Center, the Therapeutics for Rare and Neglected Diseases program, and the Toxicology in the 21st Century program. Before joining NIH (2002), he led genomic-based target discovery, pharmacogenomic, and neuropsychiatric drug-development programs at Merck. He earned an A.B. from Princeton University, an M.D. from Harvard Medical School, and completed training in internal medicine and neurology at Massachusetts General Hospital. In 2016, Dr. Austin was elected chair of the International Rare Disease Research Consortium; he is a member of National Academy of Medicine.

Panel Appearances

Future of Health Summit 2018

Creating a Culture of Biomedical Innovation